During the past decade, Washington Adventist Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 11 clinical trials were completed, i.e. on average, 157.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington Adventist Hospital" #1 sponsor was "Boston Scientific Corporation" with 10 trials, followed by "Abbott Medical Devices" with 8 trials sponsored, "Medstar Health Research Institute" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "Abiomed Inc." with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Adventist Hospital" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Washington Adventist Hospital" are "Coronary Artery Disease" (16 trials), "Myocardial Ischemia" (4 trials), "Atrial Fibrillation" (3 trials), "Coronary Artery Stenosis" (3 trials) and "Acute Coronary Syndrome" (2 trials). Many other conditions were trialed in "Washington Adventist Hospital" in a lesser frequency.

Most popular intervention types in "Washington Adventist Hospital" are "Device" (31 trials), "Drug" (12 trials), "Other" (3 trials), "Procedure" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAXUS Liberté-SR" (3 trials), "Express2" (2 trials), "TAXUS™ Express" (2 trials), "XIENCE V® Everolimus Eluting Coronary Stent" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Washington Adventist Hospital" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Washington Adventist Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Washington Adventist Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Washington Adventist Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".

Washington Adventist Hospital has several departments that took part in Clinical trials: "Adventist Healthcare Rehabilitation" - 2 trials